MALIGNANT GLIOMA

Clinical trials for MALIGNANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT GLIOMA trials appear

Sign up with your email to follow new studies for MALIGNANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 1 Not yet finished but already full! 13 Completed 5 Terminated 1

New hope for brain cancer: immune booster and drug combo tested

Disease control Not yet recruiting

This study tests two drugs—retifanlimab (an immunotherapy that helps the immune system attack cancer) and DFMO (which slows tumor growth)—in people with progressive high-grade gliomas, aggressive brain tumors. The goal is to find the safest and most effective dose and see if the …

Matched conditions: MALIGNANT GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 08, 2026 12:01 UTC

MALIGNANT GLIOMA

Get alerted when new MALIGNANT GLIOMA trials appear

New hope for brain cancer: immune booster and drug combo tested